RETEVMO 120 mg/1 (Selpercatinib TABLET, COATED) 120 mg/1

RETEVMO 120 mg tablets are a prescription medication used to treat specific types of cancer. This oral treatment is designed to target certain genetic mutations, offering a targeted approach to cancer therapy.

Strength

120 mg/1

Pack Size

60 TABLET, COATED in 1 BOTTLE (0002-6120-60)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETEVMO 120 mg tablets are primarily used in the treatment of advanced or metastatic cancers that harbor specific genetic alterations. These tablets are often prescribed for cancers that have spread to other parts of the body or are resistant to other treatments. RETEVMO is designed to target and inhibit the activity of certain proteins that drive cancer growth, providing a targeted therapeutic option for patients with these genetic mutations.

Side Effects

Common effects of RETEVMO 120 mg tablets may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, dry skin, or changes in taste. These effects can vary in severity and duration, and it's important to discuss any persistent or concerning symptoms with a healthcare provider.

Precautions & Warnings

RETEVMO 120 mg tablets should be handled with care and stored as directed. It's important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Avoid Interactions

RETEVMO 120 mg tablets may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It's important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of RETEVMO.

Frequently Asked Questions

RETEVMO 120 mg tablets are used to treat specific types of cancer that have certain genetic mutations.

RETEVMO 120 mg tablets are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include gastrointestinal issues, fatigue, dry skin, and changes in taste.

It's important to consult a healthcare provider before taking RETEVMO 120 mg with other medications to avoid potential interactions.

Pregnant women or those planning to become pregnant should consult their healthcare provider before using RETEVMO 120 mg.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.